1,3-Diarylpyrazolyl-acylsulfonamides as Potent Anti-tuberculosis Agents Targeting Cell Wall Biosynthesis in <i>Mycobacterium tuberculosis</i>
Lutete Peguy Khonde, Rudolf Müller, Grant A. Boyle, Virsinha Reddy, Aloysius T. Nchinda, Charles J. Eyermann, Stephen Fienberg, Vinayak Singh, Alissa Myrick, Efrem Abay, Mathew Njoroge, Nina Lawrence, Qin Su, Timothy G. Myers, Helena I. Boshoff, Clifton E. Barry, Frederick A. Sirgel, Paul D. van Helden, Lisa M. Massoudi, Gregory T. Robertson, Anne J. Lenaerts, Gregory S. Basarab, Sandeep R. Ghorpade, Kelly Chibale
Abstract
efficacy proof-of-concept studies.
Topics & Concepts
Mycobacterium tuberculosisINHAPharmacophoreIn vivoChemistryTuberculosisIn vitroMode of actionIsoniazidBiochemistryMicrobiologyBiologyMedicineBiotechnologyPathologyTuberculosis Research and EpidemiologyQuinazolinone synthesis and applicationsSynthesis and Catalytic Reactions